These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1743630)

  • 1. Pediatric non-Hodgkin's lymphoma abdominal presentations: a comparative study between two treatment regimens at the National Cancer Institute Cairo.
    Abdel Hadi SS; el Taneer OM; Hussein MH; el Haddad A; el Badawi S; Mokhtar N; Hamza MR; el Mawla NG
    Hematol Oncol; 1991; 9(4-5):275-9. PubMed ID: 1743630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
    Mottl H; Bajciova V; Nemec J; Al Shemmari S; Al Awadi S
    Pediatr Hematol Oncol; 2003 Mar; 20(2):103-10. PubMed ID: 12554521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood non-Hodgkin's lymphoma in Egypt: preliminary results of treatment with a new ifosfamide-containing regimen.
    Gad-el-Mawla N; Hussein MH; Abdel-Hadi S; el-Taneer O; Adde M; Magrath I
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S20-3. PubMed ID: 2758567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged disease-free survival in pediatric non-Hodgkin's lymphoma using ifosfamide-containing combination chemotherapy.
    Gad-el-Mawla N; Hamza MR; Abdel-Hadi S; el-Tannir O; Hussein MH; el-Haddad A; Adde M; Magrath I
    Hematol Oncol; 1991; 9(4-5):281-6. PubMed ID: 1743631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre combined chemotherapy protocol for large cell advanced non Hodgkin's lymphoma.
    Dumont J; Charpy-Validire P; Mosseri V; Gabarre J; Belanger C; Turpin F; Binet JL; Dreyfus F; Fourquet A; Janvier M
    Hematol Oncol; 1991; 9(4-5):197-207. PubMed ID: 1720759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma after failure of the LNH 84 regimen.
    Herbrecht R; Ortiz S; Damonte JC; Liu KL; Maloisel F; Dufour P; Bergerat JP; Oberling F
    Hematol Oncol; 1991; 9(4-5):253-7. PubMed ID: 1720760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment.
    Lobo-Sanahuja F; García I; Barrantes JC; Barrantes M; Jiménez R; Argüello A
    Med Pediatr Oncol; 1994; 22(3):194-9. PubMed ID: 8272009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Hodgkin's lymphoma in children. Results of therapy.
    Cáp J; Misíková Z; Foltinová A
    Neoplasma; 1987; 34(6):735-44. PubMed ID: 2448663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
    Shimizu H; Kikuchi M; Takaue Y; Utsumi J; Takeda T; Fujimoto T
    Int J Hematol; 1995 Feb; 61(2):85-96. PubMed ID: 7734716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
    Arellano-Rodrigo E; López-Guillermo A; Bessell EM; Nomdedeu B; Montserrat E; Graus F
    Eur J Haematol; 2003 Apr; 70(4):219-24. PubMed ID: 12656744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin's aggressive lymphoma: a pilot study.
    Inoue R; Natazuka T; Shimoyama M; Tamekane A; Kajimoto Y; Iwata N; Matsuoka H; Chihara K; Matsui T
    Leuk Lymphoma; 2000 Jan; 36(3-4):315-21. PubMed ID: 10674903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.
    Sawada M; Tsurumi H; Yamada T; Hara T; Fukuno K; Goto H; Shimizu M; Kasahara S; Yoshikawa T; Kanemura N; Oyama M; Takami T; Moriwaki H
    Eur J Haematol; 2002 Jun; 68(6):354-61. PubMed ID: 12225393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
    Magrath I; Adde M; Shad A; Venzon D; Seibel N; Gootenberg J; Neely J; Arndt C; Nieder M; Jaffe E; Wittes RA; Horak ID
    J Clin Oncol; 1996 Mar; 14(3):925-34. PubMed ID: 8622041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
    Toogood IR; Tiedemann K; Stevens M; Smith PJ
    Med Pediatr Oncol; 1993; 21(2):103-10. PubMed ID: 8433675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abdominal presentation of B-cell non-Hodgkin's lymphoma (B-NHL) - surgical treatment and its results. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Kazanowska B; Wróbel G; Jaworski W; Bogusławska-Jaworska J; Jeleń M; Armata J; Balcerska A; Bubala H; Dluzniewska A; Kołecki P; Kowalczyk J; Kurylak A; Matysiak M; Ploszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopylo B; Stańczak E; Stefaniak MJ; Stefańska K; Wysocki M; Gacka M
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):57-66. PubMed ID: 12021463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.